When Is Imiquimod Treatment Recommended for Genital Warts?

Imiquimod is a topical immune-response modifier. It does not directly destroy HPV and it is not appropriate for every genital lesion. A clinician should confirm that the growth is a wart and identify whether it is on external skin; internal vaginal, cervical, urethral, or anal lesions need specialist guidance rather than unsupervised application.

Treatment choice can depend on the number, size, thickness, and position of warts, as well as pregnancy, immune health, skin sensitivity, and previous treatment. Burning, redness, swelling, soreness, and crusting can occur where the cream is used.

Apply only the prescribed amount to the prescribed external area and follow the exact schedule. Wash hands before and after use, allow the product to remain for the instructed time, and wash it off as directed. Avoid sexual contact while the cream is on the skin because it may irritate a partner or weaken some barrier materials.

Tell the clinician if you are pregnant, trying to conceive, breastfeeding, immunocompromised, or using other products on the area. Do not share the cream or treat a new growth without an examination.

Seek prompt assessment for a bleeding, ulcerated, very painful, hard, pigmented, or rapidly changing growth, or for difficulty passing urine. Contact the prescriber if swelling, pain, rash, or skin breakdown is severe or extends beyond the treated area.

Has this growth been confirmed as an external genital wart? Which areas should receive cream, and which must be avoided? What reaction is expected? When should the result be checked, and what alternatives are available if the skin cannot tolerate treatment?